An interventional study of follitropin and lutropin in Galactosemia and Premature Ovarian Failure, sponsored by Maastricht University Medical Center. Status unknown at 1 site in Netherlands. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2010-01-12.
Sponsored by Maastricht University Medical Center · Not applicable and Interventional
The aim of the study is to investigate whether inactive FSH plays a role in the development of Premature Ovarian Failure in women with Classic Galactosemia
172 studies on the registry are indexed under Primary Ovarian Insufficiency; 45 are open to participants now.
This study's planned enrollment of 25 is below the median of 49 across 109 interventional studies indexed under Primary Ovarian Insufficiency.
Browse Primary Ovarian Insufficiency studies →Maastricht University Medical Center is the lead sponsor of 835 studies on the registry; 122 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: follitropin and lutropin
follitropin and lutropin
Estradiol response
Time frame: 3 days
This study is status unknown, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Galactosemias
Maastricht University Medical Center